A selection of abstracts of clinically relevant papers from other journals. The abstracts on this page have been chosen and edited by John R. Radford.
Abstract
Almost one third of those patients who used the daily fluoride rinse developed at least one white spot lesion.
Main
van der Kaaij NCW, van der Veen MH et al. Eur J Oral Sci 2015;123: 186–193
But this was significantly less than the participants who used the placebo rinse (31% fluoride v 47% placebo, p = 0.038). In this triple-blind, placebo-controlled study randomised control study, white spot lesions were recorded in 81 patients undergoing orthodontic treatment. White spot lesions were recorded using quantitative light-induced fluorescence and ICDAS before treatment and 6 weeks following debonding. Of note, there was no difference in white spot lesions when measured using ICDAS. Patients used either a combination of 100 ppm amine fluoride and 150 ppm sodium fluoride (elmex®; Colgate-Palmolive Europe), or a placebo. The mouthrinse was used each evening after toothbrushing. The mean time of orthodontic treatment was just over 2 years. These observations should be considered in the light that the study was carried out in an orthodontic department that has a 'stringent oral hygiene protocol'. When comparing gingival bleeding, there were no differences between the fluoride and placebo mouthrinse groups.
Rights and permissions
About this article
Cite this article
A prospective, randomized placebo-controlled clinical trial on the effects of a fluoride rinse on white spot lesion development and bleeding in orthodontic patients. Br Dent J 219, 261 (2015). https://doi.org/10.1038/sj.bdj.2015.708
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bdj.2015.708